Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Acetylcysteine, Theophylline, and a Combination of Both in the Prophylaxis of Contrast-Induced Nephropathy (ATHENS)
This study has been completed.
Study NCT00492518 Information provided by Technische Universität München
First Received on June 26, 2007. No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Contrast Induced Nephropathy
Kidney Diseases
Renal Failure
Adverse Effects
Additional conditions recognized in this trial
Renal Insufficiency
More general conditions related to this trial
Urologic Diseases
Interventions listed in this trial
Acetylcysteine
Theophylline
Placebo
Additional drug interventions recognized in this trial
N-monoacetylcystine
More general drug interventions related to this trial
Anti-Asthmatic Agents
Anti-Infective Agents
Antidotes
Antioxidants
Antiviral Agents
Autonomic Agents
Bronchodilator Agents
Cardiovascular Agents
Enzyme Inhibitors
Expectorants
Free Radical Scavengers
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Phosphodiesterase Inhibitors
Physiological Effects of Drugs
Protective Agents
Purinergic Agents
Purinergic Antagonists
Purinergic P1 Receptor Antagonists
Respiratory System Agents
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Technische Universität München
Back to top of Main Content